title: HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial.
abstract: OBJECTIVE
  Ventilation strategies for preterm neonates may influence the severity of pulmonary dysfunction and later development of chronic lung disease. The objective of this report is to compare the effects of high-frequency oscillatory ventilation (HFOV) versus synchronized intermittent mandatory ventilation (sIMV) from the points of views of biochemical and functional variables.
  
  
  METHODS
  Randomized controlled trial.
  
  
  METHODS
  Third level NICU.
  
  
  METHODS
  Forty preterm neonates with a gestational age of 24-29 weeks were randomly assigned to one of the two above-mentioned ventilation strategies within 30 min from birth.
  
  
  RESULTS
  At 1, 3, 5, and 7 days, the babies were monitored by means of ventilator indices, pulmonary function, and eight pro-inflammatory or anti-inflammatory cytokines measured in bronchoalveolar lavage fluid. The neonates assigned to the HFOV procedure benefited from early and sustained improvement in pulmonary mechanics and gas exchange-significantly higher dynamic respiratory compliance values, significantly lower expiratory airway resistance and oxygenation index values-with earlier extubation as compared to the neonates assigned to sIMV treatment, and showed significantly lower transforming growth factor-beta1 concentrations in bronchoalveolar lavage fluid.
  
  
  CONCLUSIONS
  The results of this randomized clinical trial support the hypothesis that early and exclusive use of HFOV, combined with optimum volume strategy, has a beneficial effect during the acute phase of lung injury.
authors.affiliation: Division of Neonatology, Department of Paediatrics, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome, Italy. vento@rm.unicatt.it
authors.forename: Giovanni
authors.initials: G
authors.lastname: Vento
authors.forename: Piero G
authors.initials: PG
authors.lastname: Matassa
authors.forename: Franco
authors.initials: F
authors.lastname: Ameglio
authors.forename: Ettore
authors.initials: E
authors.lastname: Capoluongo
authors.forename: Enrico
authors.initials: E
authors.lastname: Zecca
authors.forename: Luca
authors.initials: L
authors.lastname: Tortorolo
authors.forename: Mara
authors.initials: M
authors.lastname: Martelli
authors.forename: Costantino
authors.initials: C
authors.lastname: Romagnoli
mesh_terms: D001826:Body Fluids / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D006612:High-Frequency Ventilation; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D012121:Respiration, Artificial / Q000379:methods; D012127:Respiratory Distress Syndrome, Newborn / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D015656:Respiratory Mechanics; D020545:Respiratory Mucosa / Q000276:immunology* / Q000378:metabolism*; D016019:Survival Analysis; D016212:Transforming Growth Factor beta / Q000378:metabolism; D053773:Transforming Growth Factor beta1; D016896:Treatment Outcome
chemical_list: D016207:Cytokines; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1
references.citation: Eur Respir J. 2000 Jan;15(1):217-31
references.pmid: 10678650
references.citation: Am J Respir Crit Care Med. 2003 Nov 1;168(9):1051-9
references.pmid: 12816737
references.citation: J Appl Physiol (1985). 1986 Feb;60(2):532-8
references.pmid: 3512509